Showing results (461-470 of 517) with videos related to

Sort By:
Pageof 52
Molecular Therapy. Nucleic Acids|January 8, 2024
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus responseEmilia Alors-Pérez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, et al.
Journal of Clinical Medicine|September 11, 2019
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate CancerEnrique Gómez-Gómez, Juan M. Jiménez-Vacas, Sergio Pedraza-Arévalo, et al.
Scientific Reports|March 5, 2015
In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive featuresAlejandro Ibáñez-Costa, Manuel D Gahete, Esther Rivero-Cortés, et al.
Nutrition & Diabetes|May 16, 2024
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trialAlicia Podadera-Herreros, Antonio P Arenas-de Larriva, Francisco M Gutierrez-Mariscal, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Reorganization of the Flagellum Scaffolding Induces a Sperm Standstill During FertilizationMartina Jabloñski, Guillermina M Luque, Matías D Gómez-Elías, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 9, 2021
Chronodisruption and diet associated with increased cardiometabolic risk in coronary heart disease patients: the CORDIOPREV studyJuan Luis Romero-Cabrera, Marta Garaulet, Jose Jimenez-Torres, et al.
The Journal of Clinical Endocrinology and Metabolism|July 26, 2013
A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implicationsR M Luque, A Ibáñez-Costa, L M López-Sánchez, et al.
Antioxidants (Basel, Switzerland)|January 26, 2024
Telomere Maintenance Is Associated with Type 2 Diabetes Remission in Response to a Long-Term Dietary Intervention without Non-Weight Loss in Patients with Coronary Heart Disease: From the CORDIOPREV Randomized Controlled TrialAna Ojeda-Rodriguez, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 26, 2022
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumorsSergio Pedraza-Arevalo, Emilia Alors-Pérez, Ricardo Blázquez-Encinas, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|July 26, 2019
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancerJuan M Jiménez-Vacas, Vicente Herrero-Aguayo, Enrique Gómez-Gómez, et al.
Pageof 52